These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 28178702)

  • 1. Dysregulation of the Expression of Asparagine-Linked Glycosylation 13 Short Isoform 2 Affects Nephrin Function by Altering Its N-Linked Glycosylation.
    Esposito T; De Stefano G; Reccia MG; Di Lorenzo I; Napolitano F; Scalabrì F; Lombardi A; Saleem MA; Griffiths LR; Gianfrancesco F
    Nephron; 2017; 136(2):143-150. PubMed ID: 28178702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alg14 recruits Alg13 to the cytoplasmic face of the endoplasmic reticulum to form a novel bipartite UDP-N-acetylglucosamine transferase required for the second step of N-linked glycosylation.
    Gao XD; Tachikawa H; Sato T; Jigami Y; Dean N
    J Biol Chem; 2005 Oct; 280(43):36254-62. PubMed ID: 16100110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique X-linked familial FSGS with co-segregating heart block disorder is associated with a mutation in the NXF5 gene.
    Esposito T; Lea RA; Maher BH; Moses D; Cox HC; Magliocca S; Angius A; Nyholt DR; Titus T; Kay T; Gray NA; Rastaldi MP; Parnham A; Gianfrancesco F; Griffiths LR
    Hum Mol Genet; 2013 Sep; 22(18):3654-66. PubMed ID: 23686279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-linked glycosylation is critical for the plasma membrane localization of nephrin.
    Yan K; Khoshnoodi J; Ruotsalainen V; Tryggvason K
    J Am Soc Nephrol; 2002 May; 13(5):1385-9. PubMed ID: 11961028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmembrane insertases and
    Talbot BE; Vandorpe DH; Stotter BR; Alper SL; Schlondorff JS
    J Biol Chem; 2019 Aug; 294(34):12655-12669. PubMed ID: 31266804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predominant and novel de novo variants in 29 individuals with ALG13 deficiency: Clinical description, biomarker status, biochemical analysis, and treatment suggestions.
    Ng BG; Eklund EA; Shiryaev SA; Dong YY; Abbott MA; Asteggiano C; Bamshad MJ; Barr E; Bernstein JA; Chelakkadan S; Christodoulou J; Chung WK; Ciliberto MA; Cousin J; Gardiner F; Ghosh S; Graf WD; Grunewald S; Hammond K; Hauser NS; Hoganson GE; Houck KM; Kohler JN; Morava E; Larson AA; Liu P; Madathil S; McCormack C; Meeks NJL; Miller R; Monaghan KG; Nickerson DA; Palculict TB; Papazoglu GM; Pletcher BA; Scheffer IE; Schenone AB; Schnur RE; Si Y; Rowe LJ; Serrano Russi AH; Russo RS; Thabet F; Tuite A; Villanueva MM; Wang RY; Webster RI; Wilson D; Zalan A; ; Wolfe LA; Rosenfeld JA; Rhodes L; Freeze HH
    J Inherit Metab Dis; 2020 Nov; 43(6):1333-1348. PubMed ID: 32681751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice with mutant Inf2 show impaired podocyte and slit diaphragm integrity in response to protamine-induced kidney injury.
    Subramanian B; Sun H; Yan P; Charoonratana VT; Higgs HN; Wang F; Lai KV; Valenzuela DM; Brown EJ; Schlöndorff JS; Pollak MR
    Kidney Int; 2016 Aug; 90(2):363-372. PubMed ID: 27350175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exome sequence identified a c.320A > G ALG13 variant in a female with infantile epileptic encephalopathy with normal glycosylation and random X inactivation: Review of the literature.
    Hamici S; Bastaki F; Khalifa M
    Eur J Med Genet; 2017 Oct; 60(10):541-547. PubMed ID: 28778787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct effect of plasma permeability factors from patients with idiopatic FSGS on nephrin and podocin expression in human podocytes.
    Doublier S; Musante L; Lupia E; Candiano G; Spatola T; Caridi G; Zennaro C; Carraro M; Ghiggeri GM; Camussi G
    Int J Mol Med; 2005 Jul; 16(1):49-58. PubMed ID: 15942677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD2-associated protein and glomerular disease.
    Wolf G; Stahl RA
    Lancet; 2003 Nov; 362(9397):1746-8. PubMed ID: 14643126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of podocyte injuries in Osborne-Mendel rats is accompanied by reduced expression of podocyte proteins.
    Yasuno K; Araki S; Sakashita H; Kobayashi R; Baba T; Kawakami H; Kamiie J; Ogihara K; Shirota K
    J Comp Pathol; 2013; 149(2-3):280-90. PubMed ID: 23582971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of nephrin gene by the Ets transcription factor, GA-binding protein.
    Ristola M; Arpiainen S; Shimokawa T; Ra C; Tienari J; Saleem MA; Holthöfer H; Lehtonen S
    Nephrol Dial Transplant; 2013 Apr; 28(4):846-55. PubMed ID: 23197680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plekhh2, a novel podocyte protein downregulated in human focal segmental glomerulosclerosis, is involved in matrix adhesion and actin dynamics.
    Perisic L; Lal M; Hulkko J; Hultenby K; Önfelt B; Sun Y; Dunér F; Patrakka J; Betsholtz C; Uhlen M; Brismar H; Tryggvason K; Wernerson A; Pikkarainen T
    Kidney Int; 2012 Nov; 82(10):1071-83. PubMed ID: 22832517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-linked protein glycosylation in the ER.
    Aebi M
    Biochim Biophys Acta; 2013 Nov; 1833(11):2430-7. PubMed ID: 23583305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-causing missense mutations in NPHS2 gene alter normal nephrin trafficking to the plasma membrane.
    Nishibori Y; Liu L; Hosoyamada M; Endou H; Kudo A; Takenaka H; Higashihara E; Bessho F; Takahashi S; Kershaw D; Ruotsalainen V; Tryggvason K; Khoshnoodi J; Yan K
    Kidney Int; 2004 Nov; 66(5):1755-65. PubMed ID: 15496146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopoietin-like protein 3 regulates the motility and permeability of podocytes by altering nephrin expression in vitro.
    Gao X; Xu H; Liu H; Rao J; Li Y; Zha X
    Biochem Biophys Res Commun; 2010 Aug; 399(1):31-6. PubMed ID: 20633534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective glycosylation of α-dystroglycan contributes to podocyte flattening.
    Kojima K; Nosaka H; Kishimoto Y; Nishiyama Y; Fukuda S; Shimada M; Kodaka K; Saito F; Matsumura K; Shimizu T; Toda T; Takeda S; Kawachi H; Uchida S
    Kidney Int; 2011 Feb; 79(3):311-6. PubMed ID: 20944549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes.
    Alfano M; Cinque P; Giusti G; Proietti S; Nebuloni M; Danese S; D'Alessio S; Genua M; Portale F; Lo Porto M; Singhal PC; Rastaldi MP; Saleem MA; Mavilio D; Mikulak J
    Sci Rep; 2015 Sep; 5():13647. PubMed ID: 26380915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte-specific deletion of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis.
    El-Aouni C; Herbach N; Blattner SM; Henger A; Rastaldi MP; Jarad G; Miner JH; Moeller MJ; St-Arnaud R; Dedhar S; Holzman LB; Wanke R; Kretzler M
    J Am Soc Nephrol; 2006 May; 17(5):1334-44. PubMed ID: 16611717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis.
    Pereira RL; Buscariollo BN; Corrêa-Costa M; Semedo P; Oliveira CD; Reis VO; Maquigussa E; Araújo RC; Braga TT; Soares MF; Moura IC; Malheiros DM; Filho AP; Keller AC; Câmara NO
    Kidney Int; 2011 Jun; 79(11):1217-27. PubMed ID: 21412216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.